HCR — Health Issues
Provide advice and strategic counsel with regard to matters that could impact biopharmaceutical manufacturers generally and Amgen specifically, including Medicare Part D, Medicare Part B, Health Care Reform, Medicaid, FDA regulatory issues, and corporate tax reform.
Lobbyists:
- ROBERT WOOD — covered position: Chief of Staff to HHS Secretary; Intern to Rep. Scott Klug
- BRENT ALAN DEL MONTE — covered position: Leg. Dir. Rep. Bliley; Sen. Counsel House Energy & Commerce Committee
- ROBB WALTON — covered position: Senior Health Policy Advisor and Counsel Sen Cassidy; Advisor Rep. Cassidy; Research Asst., Staff Asst., Intern on Senate HELP, Ranking Member, Sen. Enzi; Intern to Rep. Nunes
- JOHN STONE — covered position: Counsel, House E&C Cmte, Oversight Subcommittee; Senior Counsel, House E&C Cmte, Health Subcommittee; Intern, House E&C
- ms REMY LEIGH BRIM MASON — covered position: Senior FDA Policy Advisor to Senate HELP Committee Ranking Member Patty Murray; Senior Health Policy Advisor Sen. Elizabeth Warren; Intern to Rep. Allyson Schwartz
- JOEL D. BAILEY — covered position: COS Rep. Panetta; LD Rep. Ashford; LD Rep. Matheson; Sr. LA Rep. Matsui; LA, Sr. LA Rep. Baron Hill; Intern Rep. Rahall
- RAGHAV AGGARWAL — covered position: Health Insurance Specialist, CMS; Senior Health Advisor (Detailee), Senate Finance Committee/Sen. Ron Wyden; Social Science Research Analyst, CMS; Intern, Sen. Feinstein; Secretarys Fellow, US Dept. of Interior [new]
Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE